Cannabis Bioscience Expands Board, Adds Key M&A Expert

Don't Miss our Black Friday Offers:

Cannabis Bioscience International Holdings ( (CBIH) ) has shared an announcement.

On November 22, 2024, the Board expanded its directors to include Charles Tamburello, leveraging his expertise in mergers and acquisitions. Tamburello, previously CEO of Global Discovery Group, will receive equity compensation for his role, with specific conditions on resignation or removal. The agreement includes indemnification against potential liabilities and confidentiality clauses regarding proprietary information. Additionally, a nondisclosure agreement was established between the Registrant and Global, ensuring confidentiality in potential business dealings.

See more insights into CBIH stock on TipRanks’ Stock Analysis page.

Trending Articles

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.